324 related articles for article (PubMed ID: 12746135)
1. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Sigolaeva LV; Zhuravleva LV; Eremenko AV; Kurochkin IN; Malygin VV; Richardson RJ
J Toxicol Environ Health A; 2003 Apr; 66(7):599-610. PubMed ID: 12746135
[TBL] [Abstract][Full Text] [Related]
2. Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress.
Makhaeva GF; Malygin VV; Strakhova NN; Sigolaeva LV; Sokolovskaya LG; Eremenko AV; Kurochkin IN; Richardson RJ
Hum Exp Toxicol; 2007 Apr; 26(4):273-82. PubMed ID: 17615108
[TBL] [Abstract][Full Text] [Related]
3. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ
J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094
[TBL] [Abstract][Full Text] [Related]
4. Improved electrochemical analysis of neuropathy target esterase activity by a tyrosinase carbon paste electrode modified by 1-methoxyphenazine methosulfate.
Sokolovskaya LG; Sigolaeva LV; Eremenko AV; Gachok IV; Makhaeva GF; Strakhova NN; Malygin VV; Richardson RJ; Kurochkin IN
Biotechnol Lett; 2005 Aug; 27(16):1211-8. PubMed ID: 16158266
[TBL] [Abstract][Full Text] [Related]
5. Quantitative structure-activity relationships predict the delayed neurotoxicity potential of a series of O-alkyl-O-methylchloroformimino phenylphosphonates.
Malygin VV; Sokolov VB; Richardson RJ; Makhaeva GF
J Toxicol Environ Health A; 2003 Apr; 66(7):611-25. PubMed ID: 12746136
[TBL] [Abstract][Full Text] [Related]
6. Bioelectrochemical analysis of neuropathy target esterase activity in blood.
Sigolaeva LV; Makower A; Eremenko AV; Makhaeva GF; Malygin VV; Kurochkin IN; Scheller FW
Anal Biochem; 2001 Mar; 290(1):1-9. PubMed ID: 11180931
[TBL] [Abstract][Full Text] [Related]
7. The homeostasis of phosphatidylcholine and lysophosphatidylcholine was not disrupted during tri-o-cresyl phosphate-induced delayed neurotoxicity in hens.
Hou WY; Long DX; Wang HP; Wang Q; Wu YJ
Toxicology; 2008 Oct; 252(1-3):56-63. PubMed ID: 18755237
[TBL] [Abstract][Full Text] [Related]
8. Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.
Makhaeva GF; Rudakova EV; Hein ND; Serebryakova OG; Kovaleva NV; Boltneva NP; Fink JK; Richardson RJ
J Appl Toxicol; 2014 Dec; 34(12):1426-35. PubMed ID: 24395470
[TBL] [Abstract][Full Text] [Related]
9. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE).
Sogorb MA; González-González I; Pamies D; Vilanova E
Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283
[TBL] [Abstract][Full Text] [Related]
10. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors.
Wu SY; Casida JE
Toxicol Appl Pharmacol; 1996 Jul; 139(1):195-202. PubMed ID: 8685903
[TBL] [Abstract][Full Text] [Related]
11. Relative potencies of the four stereoisomers of isomalathion for inhibition of hen brain acetylcholinesterase and neurotoxic esterase in vitro.
Jianmongkol S; Berkman CE; Thompson CM; Richardson RJ
Toxicol Appl Pharmacol; 1996 Aug; 139(2):342-8. PubMed ID: 8806851
[TBL] [Abstract][Full Text] [Related]
12. Avian embryonic brain reaggregate culture system. II. NTE activity discriminates between effects of a single neuropathic or nonneuropathic organophosphorus compound exposure.
Funk KA; Liu CH; Higgins RJ; Wilson BW
Toxicol Appl Pharmacol; 1994 Jan; 124(1):159-63. PubMed ID: 8291056
[TBL] [Abstract][Full Text] [Related]
13. Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells.
Ehrich M; Correll L; Veronesi B
Neurotoxicology; 1994; 15(2):309-13. PubMed ID: 7991219
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates: interaction with neuropathy target esterase and acetylcholinesterase.
Makhaeva GF; Filonenko IV; Yankovskaya VL; Fomicheva SB; Malygin VV
Neurotoxicology; 1998; 19(4-5):623-8. PubMed ID: 9745921
[TBL] [Abstract][Full Text] [Related]
15. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase.
Kropp TJ; Richardson RJ
J Toxicol Environ Health A; 2003 Jun; 66(12):1145-57. PubMed ID: 12791540
[TBL] [Abstract][Full Text] [Related]
16. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the delayed neurotoxic potential of isopropyl triphenylphosphate using a nontraditional testing strategy.
Sprague GL; Castles TR; Bickford AA
J Toxicol Environ Health; 1984; 14(5-6):773-88. PubMed ID: 6520887
[TBL] [Abstract][Full Text] [Related]
18. Recovery of neuropathy target esterase activity after inhibition with mipafox and O-hexyl O-2,5-dichlorophenyl phosphoramidate in bovine chromaffin cell cultures.
Quesada E; Sabater E; Sogorb MA; Vilanova E; Carrera V
Chem Biol Interact; 2007 Jan; 165(2):99-105. PubMed ID: 17184757
[TBL] [Abstract][Full Text] [Related]
19. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase.
Moretto A; Bertolazzi M; Lotti M
Toxicol Appl Pharmacol; 1994 Nov; 129(1):133-7. PubMed ID: 7974486
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neurotoxic esterase in vitro by novel carbamates.
Randall JC; Ambroso JL; Groutas WC; Brubaker MJ; Richardson RJ
Toxicol Appl Pharmacol; 1997 Mar; 143(1):173-8. PubMed ID: 9073605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
